Purchases and Sales Made in Q1 2022 in Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO) during Q1 2022. The information is specifically focused on institutions that hold shares of BridgeBio Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-290KClosed |
$2.13M - $4.98M
|
0
$0
|
|
|
May 10, 2022
Q1 2022
|
Nicholas Investment Partners, LP
Rancho Santa Fe, CA |
SELL
|
- |
-295KClosed |
$2.16M - $5.06M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-328KClosed |
$2.41M - $5.63M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Partners Capital Investment Group, LLP
Boston, MA |
SELL
|
- |
-483K- 99.72% |
$3.55M - $8.29M
|
1.37K
$50.5K
|
|
|
May 13, 2022
Q1 2022
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-494KClosed |
$3.63M - $8.48M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-578K- 38.65% |
$4.24M - $9.92M
|
918K
$33.8M
|
|
|
May 05, 2022
Q1 2022
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
SELL
|
- |
-764KClosed |
$5.6M - $13.1M
|
0
$0
|
|
|
May 11, 2022
Q1 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-795K- 51.51% |
$5.83M - $13.6M
|
748K
$27.6M
|
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-901KClosed |
$6.62M - $15.5M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Alberta Investment Management Corp
Edmonton, A0 |
SELL
|
- |
-1MClosed |
$7.34M - $17.2M
|
0
$0
|
|
|
May 13, 2022
Q1 2022
|
Rockefeller Capital Management L.P.
New York, NY |
SELL
|
- |
-1.02M- 91.86% |
$7.48M - $17.5M
|
90.3K
$3.33M
|
|
|
May 16, 2022
Q1 2022
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-3.29M- 46.14% |
$24.1M - $56.4M
|
3.84M
$141M
|